3-(4-fluoro-2-methoxyphenoxy)-N-(2-methylsulfonyl-4-pyridinyl)-6-(trifluoromethyl)pyridazine-4-carboxamide
C19H14F4N4O5S — CID 167198466
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(4-fluoro-2-methoxyphenoxy)-N-(2-methylsulfonyl-4-pyridinyl)-6-(trifluoromethyl)pyridazine-4-carboxamide
3-(4-fluoro-2-methoxyphenoxy)-N-(2-methylsulfonyl-4-pyridinyl)-6-(trifluoromethyl)pyridazine-4-carboxamide (PubChem CID 167198466) has the molecular formula C19H14F4N4O5S and a molecular weight of 486.40 g/mol. Its IUPAC name is 3-(4-fluoro-2-methoxyphenoxy)-N-(2-methylsulfonyl-4-pyridinyl)-6-(trifluoromethyl)pyridazine-4-carboxamide.
Molecular Properties
| Compound Name | 3-(4-fluoro-2-methoxyphenoxy)-N-(2-methylsulfonyl-4-pyridinyl)-6-(trifluoromethyl)pyridazine-4-carboxamide |
|---|---|
| PubChem CID | 167198466 |
| Molecular Formula | C19H14F4N4O5S |
| Molecular Weight | 486.40 g/mol |
| Exact Mass | 486.06 |
| IUPAC Name | 3-(4-fluoro-2-methoxyphenoxy)-N-(2-methylsulfonyl-4-pyridinyl)-6-(trifluoromethyl)pyridazine-4-carboxamide |
| SMILES | COc1cc(F)ccc1Oc1nnc(C(F)(F)F)cc1C(=O)Nc1ccnc(S(C)(=O)=O)c1 |
| InChI | InChI=1S/C19H14F4N4O5S/c1-31-14-7-10(20)3-4-13(14)32-18-12(9-15(26-27-18)19(21,22)23)17(28)25-11-5-6-24-16(8-11)33(2,29)30/h3-9H,1-2H3,(H,24,25,28) |
| InChIKey | GNXGKDIXOGQGMO-UHFFFAOYSA-N |
| XLogP | 3.49 |
| TPSA | 120.37 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.40 |
| LogP ≤ 5 | 3.49 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167198466 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.